<DOC>
	<DOCNO>NCT00039572</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy boron neutron capture therapy may kill tumor cell without harm normal tissue . PURPOSE : Phase I/II trial study effectiveness boron neutron capture therapy treat patient glioblastoma multiforme melanoma metastatic brain .</brief_summary>
	<brief_title>Boron Neutron Capture Therapy Treating Patients With Glioblastoma Multiforme Melanoma Metastatic Brain</brief_title>
	<detailed_description>OBJECTIVES : - Determine time course , uniformity , severity acute chronic normal tissue reaction patient glioblastoma multiforme intracranial melanoma treat boronophenylalanine-fructose complex ( BPA-f ) follow cranial neutron irradiation use new fission converter beam facility . - Determine maximum tolerate dose cranial neutron capture therapy patient . - Determine , serial objective measurement , clinical response patient treat therapy . - Determine pharmacokinetics BPA-f patient . OUTLINE : This dose-escalation study cranial neutron capture therapy ( NCT ) . Patients receive boronophenylalanine-fructose complex IV 90 minute follow cranial NCT day 1 2 . Cohorts 3-6 patient receive escalate dos NCT maximum tolerate dose ( MTD ) determine . The MTD define dose precede least 2 6 patient experience dose-limiting toxicity . Once MTD determine , additional patient treat MTD . Patients follow 1 , 2 , 4 , 6 , 9 , 12 month every 6 month 2 year . PROJECTED ACCRUAL : A total 16 patient accrue study within 2 year .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm glioblastoma multiforme OR Radiographically diagnose brain metastasis diagnosis melanoma Contrastenhanced tumor volume must exceed 60 mL PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : At least 6 month Hematopoietic : Not specify Hepatic : Not specify Renal : Creatinine normal Cardiovascular : No prior severe cardiac disease , include follow : Uncontrolled arrhythmias conduction defect Unstable newly diagnose angina pectoris Recent coronary artery disease Congestive heart failure Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception least 6 month study No prior phenylketonuria No cognitive impairment would preclude informed consent PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior cranial irradiation Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2002</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>tumor metastatic brain</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>